Document is current
Any future updates will be listed below
-
Authors
Spiro, Anna E. https://orcid.org/0000-0002-3465-4606
Tu, Xinming https://orcid.org/0009-0004-0833-6876
Sheng, Yilun
Sasse, Alexander
Hosseini, Rezwan https://orcid.org/0000-0001-6207-4628
Chikina, Maria https://orcid.org/0000-0003-2550-5403
Mostafavi, Sara https://orcid.org/0000-0003-4698-1177
-
Funding
Funding for this research was provided by:
DH | National Institute for Health Research (R01HG013724)
Canadian Institute for Advanced Research
- License Information
-
More Information
Article History
Received: 14 February 2025
Accepted: 13 May 2026
First Online: 8 June 2026
Competing interests
: S.M. has been an employee of Genentech since 28 November 2024, and has equity in Roche. The remaining authors declare no competing interests.
